Heart Failure News and Research RSS Feed - Heart Failure News and Research

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Scientists find that daily dose of beetroot juice significantly improves exercise endurance, blood pressure

Scientists find that daily dose of beetroot juice significantly improves exercise endurance, blood pressure

Scientists at Wake Forest Baptist Medical Center have found that a daily dose of beetroot juice significantly improved exercise endurance and blood pressure in elderly patients with heart failure with preserved ejection fraction (HFPEF). [More]
Cardiac MRI imaging assesses myocardial damage

Cardiac MRI imaging assesses myocardial damage

In a world-first, researchers from Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) have performed cardiac MRI imaging using a 7T MRI scanner in a patient-based study. [More]
Neutrophils promote cardiac repair

Neutrophils promote cardiac repair

Following an acute heart attack, immune cells called neutrophils coordinate an inflammatory response which can exacerbate the damage to the organ. Now researchers from Ludwig-Maximilians-Universitaet in Munich have shown that neutrophils also promote cardiac repair. [More]
Muscle protein titin plays vital role in Frank-Starling mechanism

Muscle protein titin plays vital role in Frank-Starling mechanism

Researchers at Illinois Institute of Technology and Loyola University have discovered new clues in the 100-year-old mystery of the Frank-Starling law of the heart: What makes the heart contract more strongly at longer lengths given the same level of calcium activation? [More]
Some heart disease drugs, antibiotics show promising perspectives in treating cancers

Some heart disease drugs, antibiotics show promising perspectives in treating cancers

North American researchers have identified drugs that showed promising perspectives in treating cancers, according to a recent study published in Cancer Research. [More]
Study provides insights into molecular basis of Frank-Starling regulatory mechanism

Study provides insights into molecular basis of Frank-Starling regulatory mechanism

In a finding that could lead to new drugs to treat heart failure, researchers have uncovered the molecular mechanism that regulates how the heart pumps blood. [More]
Scientists develop potential treatment to prevent hypertrophic cardiomyopathy

Scientists develop potential treatment to prevent hypertrophic cardiomyopathy

More than 15 years ago, David Warshaw, Ph.D., and coworkers discovered the precise malfunction of a specific protein in the heart that leads to hypertrophic cardiomyopathy, a common culprit in cases of sudden death in young athletes. [More]
NJHF awards 30 grants for NJ researchers working on health-related research

NJHF awards 30 grants for NJ researchers working on health-related research

New Jersey Health Foundation has awarded 30 grants totaling more than $1 million for researchers in New Jersey who are working on health-related research that demonstrates exciting potential. [More]
Researchers use new method to assess quality of colonoscopies performed in outpatient facilities

Researchers use new method to assess quality of colonoscopies performed in outpatient facilities

Colonoscopies are now a routine preventive diagnostic test for millions of Americans each year. While rates are low, complications like perforation, bleeding, and anesthesia-related heart failure can occur. Yale School of Medicine researchers have now developed a quality measure that uses follow-up hospital visits to track the variation in colonoscopy quality among outpatient facilities. [More]
UI researchers remind US doctors to watch for two diseases that could be passed from mother to child

UI researchers remind US doctors to watch for two diseases that could be passed from mother to child

While world health leaders race to contain the spread of the mosquito-borne Zika virus in the Americas, researchers at the University of Iowa are reminding doctors in the United States to be on the lookout for two other vector-borne and potentially life-threatening diseases that can be passed from mother to child through the placenta. [More]
NJHA honors several individuals and organizations with Healthcare Leader Awards

NJHA honors several individuals and organizations with Healthcare Leader Awards

The New Jersey Hospital Association, the state's oldest and largest healthcare trade association, today held its annual awards program to honor several individuals and organizations for their commitment to the state's healthcare system and the patients and communities they serve. [More]
Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai Inc. announced today that the U.S. Food and Drug Administration approved Halaven (eribulin mesylate) Injection (0.5 mg per mL) for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen. [More]
New SBP research may lead to novel approach to treat heart failure

New SBP research may lead to novel approach to treat heart failure

More than 5 million people in the United States suffer from heart failure, according to the American Heart Association. Less than half of those with heart failure live five years after diagnosis. [More]
New technique may reduce need for amputation in patients with critical limb ischemia

New technique may reduce need for amputation in patients with critical limb ischemia

A new imaging technique could reduce the need for amputation in patients with critical limb ischemia, according to a study publised today in the scientific journal JACC. [More]
Involving family members in care may reduce hospital readmissions

Involving family members in care may reduce hospital readmissions

A new study finds that educating and involving family members in the care of a loved one who has memory loss may significantly reduce hospital readmissions. [More]
Research provides new molecular insight into heart failure

Research provides new molecular insight into heart failure

More than 5 million people in the United States suffer from heart failure, according to the American Heart Association. Less than half of those with heart failure live five years after diagnosis. [More]
Study shows regular caffeine consumption does not lead to extra heartbeats

Study shows regular caffeine consumption does not lead to extra heartbeats

Contrary to current clinical belief, regular caffeine consumption does not lead to extra heartbeats, which, while common, can lead in rare cases to heart- or stroke-related morbidity and mortality, according to UC San Francisco researchers. [More]
Early diagnosis, treatment of sleep apnea may reduce hospital readmissions for heart failure patients

Early diagnosis, treatment of sleep apnea may reduce hospital readmissions for heart failure patients

Early diagnosis and treatment of sleep apnea may reduce six-month readmissions for patients hospitalized with heart failure, according to research recently published online by the American Journal of Cardiology. [More]
CNIC researchers identify how two proteins control heart growth and adaptation to hypertension

CNIC researchers identify how two proteins control heart growth and adaptation to hypertension

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III have identified how two proteins control the growth of the heart and its adaptation to high blood pressure (hypertension). [More]
Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be approved in Japan. [More]
Advertisement